How Cypress Hemp is Taking a Function-First Approach to Cannabis Wellness

Founded in 2017 with roots in Louisiana and Virginia, Cypress Hemp has built its business around functional cannabis products aimed at specific wellness needs.

Credit: Cypress Hemp

Its range spans gummies, oils, soft gels, topicals, THC beverages, and pet products, with formulations designed for areas such as sleep, stress, energy, calm, and physical relief. The company reports selling more than 25 million gummies since its creation and currently describes itself as Virginia’s number one hemp company.

Its operations now span three states, with farming and other activities in Louisiana and Virginia and a fulfillment warehouse in Texas. Products are also available through retail storefronts in more than a dozen states, primarily across the Southeast and Midwest. Direct-to-consumer shipping reaches more than 40 legal U.S. states.

Rather than concentrating on single-cannabinoid products, the company pairs cannabinoids with ingredients including adaptogens, nootropics, vitamins, minerals, and medicinal mushrooms. This approach reflects its broader positioning: cannabis as one component of functional wellness rather than simply a recreational product.

Formulations Target Specific Everyday Needs: Gummies are central to the company’s product range. Options include live resin THC gummies, Delta-8 gummies, microdose products, THC-dominant formulas, and its Functional Triplets for Everyday, Energy, and Sleep.

The live resin products use cannabis frozen immediately after harvest, a process intended to retain the plant’s fresh terpene profile. Other gummies focus on combinations of CBD, THC, CBG, and CBN alongside ingredients such as Reishi, Lion’s Mane, Ashwagandha, Rhodiola, and L-Theanine.

Co-founder Kristy’s degree in Biological & Agricultural Engineering provides a technical background for the company’s in-house formulation work. Before the business launched, she had experience across several areas of hemp, including processing hemp grain and laboratory testing CBD for purity.

The wider scientific picture surrounding cannabis remains nuanced. A review published in The Lancet Regional Health - Europe concluded that findings on medical cannabis “may produce small to modest benefits,” particularly in areas including chronic pain, muscle spasticity, and chemotherapy-related nausea and vomiting. Such findings provide context for the growing interest in cannabinoid products while stopping short of supporting broad wellness claims.

Cypress Hemp also applies an “Ingredients with Purpose” philosophy to its formulations. The company says it avoids artificial flavors and colors, using real fruit juices and spice extracts instead. The company prioritizes USDA-certified organic ingredients across the portfolio.

Precise Dosing Addresses a Common Consumer Question: Cannabis dosage can be difficult for new or cautious users to navigate. The company responds with products covering a wide range of cannabinoid strengths and ratios. Its gummy range starts with 2.5mg THC microdoses and extends to THC-dominant servings containing 5mg to 20mg or more. Other formulations use ratios such as 1:1, 2:5, and 1:25 to alter the balance between THC and secondary cannabinoids.

For consumers researching THC gummies, Cypress Hemp also offers Delta-8 formulations within this broader dosage-led range. The company supplements product labeling with an online Product Recommendation Quiz designed to help users understand strengths, ratios, and dosing options. Oils provide another way to adjust intake. Organic Non-GMO CBD Oil, broad-spectrum CBD products, and Full Spectrum CBD Omegas Oil come with measured droppers, allowing incremental adjustments. Broad-spectrum options are intended for consumers seeking hemp-derived cannabinoids without THC.

Research into cannabinoids also provides context for the focus on physical relief. An Institute of Medicine review quoted in the NCBI Bookshelf states that cannabinoids can provide “mild to moderate relief from pain, on a par with codeine.” However, responses to cannabinoids vary, and such research does not establish that every commercial formulation will produce the same result.

Batch Testing Places Transparency at the Center: Product purity and accurate cannabinoid labeling remain significant concerns in the hemp market. Cypress Hemp says every batch of finished product undergoes independent third-party laboratory testing, and it makes reports available to customers through its website. The policy goes beyond testing selected ingredients or occasional production runs. According to the company, the approach applies to every batch it manufactures. For customers comparing different strengths and cannabinoid ratios, batch-specific reports provide another source of information about what a product contains.

Transparency is particularly relevant for consumers who are uncertain about THC or cannabis more broadly. The company combines laboratory reports with online cannabis education covering cannabinoids, terpenes, and the endocannabinoid system. Its grassroots work has also included free hemp education classes in local churches and participation in legislative efforts concerning early state hemp laws. Medical sources continue to distinguish specific evidence-backed applications from broader claims. Mayo Clinic notes that “Research has shown that THC helps lessen nausea and vomiting in people receiving chemotherapy.” That evidence relates to a defined medical context and should not be interpreted as proof of every claimed benefit associated with consumer cannabis products.

Product Range Extends Beyond Gummies: Although gummies remain the flagship category, the company has developed products for different methods of use. Omegas Soft Gels package cannabinoids alongside adaptogens, nootropics, vitamins, and minerals. CBD Relief Balm and CBD Body Massage Oil are designed for localized application, while Hiatus THC Seltzers provide a carbonated format containing CBD and THC. Separate pet products include CBD oils and treats formulated for dogs and cats. The company is also preparing to expand beyond hemp through the broader Cypress Health Products umbrella. Planned products include tri-functional kava gummies and functional mushroom gummies aimed at focus, sleep, and immune support. This expansion broadens the functional-product model without abandoning the company’s emphasis on ingredient combinations and defined uses.

Environmental Commitments Form Part of the Business Model: Environmental activity is another part of the company’s positioning. Through a partnership with One Tree Planted, each product purchase funds one planted tree. Cypress Hemp reports that the program has funded 600,129 trees to date. It also uses plastic-free packaging void fill. The environmental program connects the company’s consumer wellness focus with its stated mission to revitalize American hemp, help people thrive, and regenerate the planet. As Cypress Hemp moves into non-hemp adaptogenic products, its combination of precise dosing, functional formulations, batch-level testing, consumer education, and environmental commitments provides a clear framework for its next stage of development.